Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online January 1, 1996.
Copyright & Usage
Copyright © 1996 by American Society of Nephrology
Author Information
Statistics from Altmetric.com
Article usage
Cited By...
In this issue
Cardiovascular disease after renal transplantation.
Jump to section
Cited By...
- New Onset Diabetes Mellitus after Transplant: The Challenge Continues
- Pre-Renal Transplant Risk Stratification: A Perpetual Quandary
- Interferon-{gamma}-Mediated Allograft Rejection Exacerbates Cardiovascular Disease of Hyperlipidemic Murine Transplant Recipients
- A Longitudinal Study of Inflammation, CKD-Mineral Bone Disorder, and Carotid Atherosclerosis after Renal Transplantation
- Serum Fetuin-A Levels Are Associated with Vascular Calcifications and Predict Cardiovascular Events in Renal Transplant Recipients
- Unusual Pattern of Dyslipidemia in Children Receiving Steroid Minimization Immunosuppression after Renal Transplantation
- TCF7L2 Polymorphism Associates with New-Onset Diabetes after Transplantation
- Sensitivity of Billing Claims for Cardiovascular Disease Events among Kidney Transplant Recipients
- Statin Use Is Associated with Prolonged Survival of Renal Transplant Recipients
- Variations in the Risk for Cerebrovascular Events after Kidney Transplant Compared with Experience on the Waiting List and after Graft Failure
- Cardiovascular Outcomes in the Outpatient Kidney Transplant Clinic: The Framingham Risk Score Revisited
- Smoking: A Risk Factor for Progression of Chronic Kidney Disease and for Cardiovascular Morbidity and Mortality in Renal Patients Absence of Evidence or Evidence of Absence?
- Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation
- Prevention of Sepsis during the Transition to Dialysis May Improve the Survival of Transplant Failure Patients
- Ischemic Heart Disease after Renal Transplantation in Patients on Cyclosporine in Spain
- No Improvement of Patient or Graft Survival in Transplant Recipients Treated with Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Type 1 Receptor Blockers: A Collaborative Transplant Study Report
- Peripheral Arterial Disease and Renal Transplantation
- Medical Care of Kidney Transplant Recipients after the First Posttransplant Year
- Early Posttransplant Serum Osteoprotegerin Levels Predict Long-Term (8-Year) Patient Survival and Cardiovascular Death in Renal Transplant Patients
- Incidence and Predictors of Myocardial Infarction after Kidney Transplantation
- New-Onset Diabetes After Transplantation 2003 International Consensus Guidelines: An endocrinologist's view
- Coronary Angiography Is the Best Predictor of Events in Renal Transplant Candidates Compared With Noninvasive Testing
- CD4 Cell Lymphopenia and Atherosclerosis in Renal Transplant Recipients
- Kidney Transplantation in the Elderly: A Decision Analysis
- Donor Hepatitis C Seropositivity: Clinical Correlates and Effect on Early Graft and Patient Survival in Adult Cadaveric Kidney Transplantation
- Sympathetic Nerve Activity in End-Stage Renal Disease
- Withdrawal of Cyclosporine or Prednisone Six Months after Kidney Transplantation in Patients on Triple Drug Therapy: A Randomized, Prospective, Multicenter Study
- Congestive Heart Failure in Renal Transplant Recipients: Risk Factors, Outcomes, and Relationship with Ischemic Heart Disease
- Peripheral Vascular Disease Risk Factors among Patients Undergoing Hemodialysis
- Lower-Extremity Peripheral Arterial Disease among Patients with End-Stage Renal Disease
- Long-Term Results of a Randomized Study Comparing Three Immunosuppressive Schedules with Cyclosporine in Cadaveric Kidney Transplantation
- Coronary Heart Disease in Chronic Renal Insufficiency: Some Management Considerations
- Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
- Explained and Unexplained Ischemic Heart Disease Risk after Renal Transplantation
- Abnormalities of endothelial function in patients with predialysis renal failure
- Homocysteine: "Expensive Creatinine" or Important, Modifiable Risk Factor for Arteriosclerotic Outcomes in Renal Transplant Recipients?
- Serum Total Homocysteine and Cardiovascular Disease Occurrence in Chronic, Stable Renal Transplant Recipients: A Prospective Study
- Enhanced Reduction of Fasting Total Homocysteine Levels With Supraphysiological Versus Standard Multivitamin Dose Folic Acid Supplementation in Renal Transplant Recipients
- Identification of Risk Factors in Hypertensive Patients : Contribution of Randomized Controlled Trials Through an Individual Patient Database
- The Clinical Epidemiology of Cardiac Disease in Chronic Renal Failure
- Body Composition in Renal Transplant Patients: Bioimpedance Analysis Compared to Isotope Dilution, Dual Energy X-Ray Absorptiometry, and Anthropometry
- Hyperhomocysteinemia in Chronic Renal Disease
- Serum Cystatin C as a Determinant of Fasting Total Homocysteine Levels in Renal Transplant Recipients with a Normal Serum Creatinine
- Elevated Fasting Total Plasma Homocysteine Levels and Cardiovascular Disease Outcomes in Maintenance Dialysis Patients : A Prospective Study
- Excess Prevalence of Fasting and Postmethionine-Loading Hyperhomocysteinemia in Stable Renal Transplant Recipients